Actively Recruiting

Age: 18Years - 50Years
FEMALE
Healthy Volunteers
NCT06184373

Early Investigation of Glucose Monitoring After Gestational Diabetes Pilot

Led by Ohio State University · Updated on 2026-01-22

20

Participants Needed

1

Research Sites

103 weeks

Total Duration

On this page

Sponsors

O

Ohio State University

Lead Sponsor

D

DexCom, Inc.

Collaborating Sponsor

AI-Summary

What this Trial Is About

One third of women with gestational diabetes (GDM), diabetes diagnosed during pregnancy, have abnormal glucose levels within 3 years after pregnancy, but follow up is low. Continuous glucose monitors (CGM), a small sensor inserted under the skin, may be able to screen women with GDM for diabetes risk. The investigators will ask postpartum women to use CGM at 6-8 weeks postpartum and answer surveys about quality of life after wearing the CGM. The investigators will collect data on blood glucose trends for future studies if participants find CGM use acceptable. The investigators hope to learn if CGM could improve postpartum follow up experiences for people with recent GDM.

CONDITIONS

Official Title

Early Investigation of Glucose Monitoring After Gestational Diabetes Pilot

Who Can Participate

Age: 18Years - 50Years
FEMALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Women with a viable singleton intrauterine pregnancy
  • Able to understand the study and provide written informed consent in English
  • Recent pregnancy affected by gestational diabetes
Not Eligible

You will not qualify if you...

  • Pregestational Diabetes (Type I or Type II)
  • Continued use of diabetes medications (including metformin and insulin) immediately after delivery
  • Preterm delivery (less than 37 weeks gestation)
  • Twin or higher order gestation
  • No access to a smartphone
  • Unable or unwilling to wear CGM or return for follow up at postpartum mother-infant dyad clinic
  • Participation in this trial in a prior pregnancy
  • History of skin allergy to adhesive products or CGM

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Ohio State University Medical Center

Columbus, Ohio, United States, 43210

Actively Recruiting

Loading map...

Research Team

R

Rachel Gordon, MD, MPH

CONTACT

S

Seuli Brill, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here